The Effect of Preoperative Oral Carbohydrate Administration on Perioperative Hypothermia in Pediatric Patients
Launched by BAŞAKŞEHIR ÇAM & SAKURA CITY HOSPITAL · May 20, 2024
Trial Information
Current as of September 17, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Patients to be operated on by the Department of Pediatric Surgery
- • 2. Being between the ages of 2 and 15
- • 3. Not restricting oral intake
- • 4. ASA I-II-III patients in anesthesia risk score
- • 5. Patients operated between 01.03.2019 and 31.07.2019
- • 6. Not having any communication problems (mental retardation, not knowing Turkish, etc.)
- • 7. Not having gastroesophageal reflux
- • 8. Not having any muscle disease
- • 9. Informed volunteer consent must be obtained
- • 10. Patients for whom emergency surgery is not planned
- • 11. No disease related to the central nervous system
- Exclusion Criteria:
- • 1. Pediatric patients outside the 2-15 age range
- • 2. Having limited oral intake
- • 3. ASA IV and above in anesthesia risk scoring
- • 4. Patients operated before 01.03.2019 or after 31.07.2019
- • 5. Patients who may have communication problems with their parents or themselves
- • 6. Patients with gastroesophageal reflux
- • 7. Patients with muscle disease
- • 8. Patients for whom informed voluntary consent has not been obtained
- • 9. Patients who will undergo emergency surgery
- • 10. Patients with diseases related to the central nervous system
About Başakşehir çam & Sakura City Hospital
Başakşehir Çam & Sakura City Hospital is a leading healthcare institution in Turkey, renowned for its state-of-the-art facilities and commitment to patient-centered care. As a prominent clinical trial sponsor, the hospital is dedicated to advancing medical research and innovation across various therapeutic areas. With a multidisciplinary team of experts and a focus on ethical practices, Başakşehir Çam & Sakura City Hospital actively collaborates with industry partners and academic institutions to facilitate cutting-edge clinical trials, aiming to improve treatment outcomes and enhance the overall quality of healthcare.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Istanbul, Turkey
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported